Using several different human normal and cancer prostate cell lines and transient engineered expression of MAP2K4, our group demonstrated that MAP2K4 increases cell invasion, a critical indication of metastatic progression in vitro[11]. This evidence concerns the gene MAP2K4 and cancer.